Skip to content
Search

Latest Stories

Submit Guest Post

Bangladesh imposes lockdown in Rohingya camps

Bangladesh has imposed a lockdown on a southern district, home to refugee camps housing more than a million Rohingya Muslims fleeing from Myanmar, to prevent the spread of coronavirus.

Officials said no-one was allowed to enter or exit Cox's Bazar district.


Cox's Bazar district head Kamal Hossain announced the measures following a rise in cases in the country as a whole.

The number of infections in Bangladesh has doubled to more than 200 in the last five days, with 20 dead.

"Entry and exit from Cox's Bazar district is prohibited from now on," Mr Hossain said in a statement, adding that "stern action" would be taken against those who violated the order.

"Only emergency food supply and medical services can continue work in the camps by maintaining extreme caution," Refugee Commissioner Mahbub Alam Talukder said.

Anyone who had arrived in the country recently would have to go into quarantine before visiting the camps, he added.

No cases are confirmed in the camps, but aid agencies fear an outbreak could overwhelm poor medical facilities.

Most refugees arrived in the camps following a military crackdown in the neighbouring state in 2017.

Almost 750,000 crossed the border, joining hundreds of thousands of refugees already living there.

Last week Human Rights Watch warned that 350,000 people within Myanmar itself were especially vulnerable to coronavirus.

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Weekly insulin jab

A weekly insulin jab could reduce the burden of daily injections for some people with type 2 diabetes

iStock

From 365 injections to 52: New weekly insulin jab could make life easier for patients

  • The treatment could reduce insulin injections from 365 a year to just 52.
  • NICE has recommended the weekly treatment, but it still needs MHRA approval.
  • People who rely on carers or struggle with daily injections could benefit most.

For some people with type 2 diabetes, managing their condition could soon involve one insulin injection a week instead of one every day.

The National Institute for Health and Care Excellence (NICE) has recommended insulin efsitora alfa, also known as Onswik and made by Eli Lilly, in its final draft guidance. If approved by the medicines regulator and subsequently rolled out on the NHS, the treatment could reduce the number of annual insulin injections from 365 to 52.

Keep ReadingShow less